Cardiovascular related polypharmacy and its association with liver and kidney impairment amongst individuals on lipid-lowering therapy: a cross-sectional study using primary care data
Event:
ESC Congress 2024
Topic:
Cardiovascular Pharmacotherapy
Session:
Lipid-lowering therapy: statins and beyond